HSIC Overview

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

Wall Street analysts forecast HSIC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSIC is76.78 USD with a low forecast of 58.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Henry Schein Inc revenue for the last quarter amounts to 3.37B USD, increased 6.31

Henry Schein Inc. EPS for the last quarter amounts to 0.92 USD, increased 4.55

Henry Schein Inc (HSIC) has 25000 emplpoyees as of May 11 2026.

Today HSIC has the market capitalization of 8.07B USD.